A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC
Clinical trial NCT02592746 · UNKNOWN
Trial details
- NCT number
- NCT02592746
- Sponsor
- Samsung Medical Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2021-06-01
- Enrollment
- 182
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.